MX2022013385A - Metodo para la produccion de aav. - Google Patents
Metodo para la produccion de aav.Info
- Publication number
- MX2022013385A MX2022013385A MX2022013385A MX2022013385A MX2022013385A MX 2022013385 A MX2022013385 A MX 2022013385A MX 2022013385 A MX2022013385 A MX 2022013385A MX 2022013385 A MX2022013385 A MX 2022013385A MX 2022013385 A MX2022013385 A MX 2022013385A
- Authority
- MX
- Mexico
- Prior art keywords
- aav
- production
- media
- spent
- during
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/10—Perfusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
- C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Sustainable Development (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20209811.7A EP4006141A1 (en) | 2020-11-25 | 2020-11-25 | Method for the production of aav |
| PCT/EP2021/082615 WO2022112218A1 (en) | 2020-11-25 | 2021-11-23 | Method for the production of aav |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022013385A true MX2022013385A (es) | 2022-11-30 |
Family
ID=73597941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022013385A MX2022013385A (es) | 2020-11-25 | 2021-11-23 | Metodo para la produccion de aav. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240263148A1 (enExample) |
| EP (3) | EP4006141A1 (enExample) |
| JP (2) | JP7601339B2 (enExample) |
| KR (1) | KR102700433B1 (enExample) |
| CN (1) | CN116209748A (enExample) |
| AU (1) | AU2021388811B2 (enExample) |
| CA (1) | CA3174017C (enExample) |
| DK (1) | DK4107252T3 (enExample) |
| ES (1) | ES3017247T3 (enExample) |
| FI (1) | FI4107252T3 (enExample) |
| IL (1) | IL296770B2 (enExample) |
| MX (1) | MX2022013385A (enExample) |
| PT (1) | PT4107252T (enExample) |
| WO (1) | WO2022112218A1 (enExample) |
| ZA (1) | ZA202210745B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202323529A (zh) * | 2021-10-18 | 2023-06-16 | 美商再生元醫藥公司 | 包括腺病毒相關病毒聚核苷酸的真核細胞 |
| TW202342740A (zh) * | 2022-03-07 | 2023-11-01 | 美商奧崔基尼克斯製藥公司 | 改良的批量aav生產系統和方法 |
| JP2025519228A (ja) * | 2022-06-03 | 2025-06-24 | エフ． ホフマン－ラ ロシュ アーゲー | 組換えａａｖ粒子を生成するための方法 |
| WO2025047766A1 (ja) * | 2023-08-29 | 2025-03-06 | 富士フイルム株式会社 | ウイルスの製造方法および細胞への核酸導入方法 |
| WO2025171001A1 (en) | 2024-02-06 | 2025-08-14 | Regeneron Pharmaceuticals, Inc. | Compositions and methods for improved production of aav viral vectors |
| WO2025168663A1 (en) | 2024-02-09 | 2025-08-14 | F. Hoffmann-La Roche Ag | Method for producing recombinant adeno-associated viral particles |
| EP4606816A1 (en) | 2024-02-26 | 2025-08-27 | Universitat Autónoma De Barcelona (UAB) | Method for production of gene therapy vehicles in mammalian cells |
| WO2025226558A1 (en) | 2024-04-22 | 2025-10-30 | Ultragenyx Pharmaceutical Inc. | Multi-step filtration and clarification methods for recombinant adeno-associated virus purification |
| WO2025252480A1 (en) | 2024-06-07 | 2025-12-11 | F. Hoffmann-La Roche Ag | Method for purifying plasmid dna |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020168342A1 (en) * | 1994-11-03 | 2002-11-14 | Cell Genesys, Inc. | Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods |
| US6989264B2 (en) * | 1997-09-05 | 2006-01-24 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| WO2000024916A1 (en) * | 1998-10-27 | 2000-05-04 | Crucell Holland B.V. | Improved aav vector production |
| US6844192B2 (en) * | 2001-06-29 | 2005-01-18 | Wake Forest University | Adenovirus E4 protein variants for virus production |
| CA3018264A1 (en) * | 2016-04-12 | 2017-10-19 | Artemis Biosystems, Inc. | Perfusion filtration systems |
| EP3456822A1 (en) * | 2017-09-19 | 2019-03-20 | CEVEC Pharmaceuticals GmbH | Inducible aav rep genes |
| EP3914696A4 (en) * | 2019-01-25 | 2022-12-14 | Biogen MA Inc. | SEED CULTIVATION METHOD FOR THE PRODUCTION OF AAV |
| EP3962536A1 (en) * | 2019-04-29 | 2022-03-09 | Voyager Therapeutics, Inc. | Systems and methods for producing baculoviral infected insect cells (biics) in bioreactors |
-
2020
- 2020-11-25 EP EP20209811.7A patent/EP4006141A1/en not_active Withdrawn
-
2021
- 2021-11-23 CA CA3174017A patent/CA3174017C/en active Active
- 2021-11-23 JP JP2022569478A patent/JP7601339B2/ja active Active
- 2021-11-23 ES ES21811385T patent/ES3017247T3/es active Active
- 2021-11-23 EP EP21811385.0A patent/EP4107252B1/en active Active
- 2021-11-23 US US18/005,027 patent/US20240263148A1/en active Pending
- 2021-11-23 EP EP25158433.0A patent/EP4596674A3/en active Pending
- 2021-11-23 DK DK21811385.0T patent/DK4107252T3/da active
- 2021-11-23 PT PT218113850T patent/PT4107252T/pt unknown
- 2021-11-23 IL IL296770A patent/IL296770B2/en unknown
- 2021-11-23 AU AU2021388811A patent/AU2021388811B2/en active Active
- 2021-11-23 WO PCT/EP2021/082615 patent/WO2022112218A1/en not_active Ceased
- 2021-11-23 CN CN202180045906.3A patent/CN116209748A/zh active Pending
- 2021-11-23 MX MX2022013385A patent/MX2022013385A/es unknown
- 2021-11-23 FI FIEP21811385.0T patent/FI4107252T3/fi active
- 2021-11-23 KR KR1020227040149A patent/KR102700433B1/ko active Active
-
2022
- 2022-09-28 ZA ZA2022/10745A patent/ZA202210745B/en unknown
-
2024
- 2024-07-11 JP JP2024111946A patent/JP2024144435A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240263148A1 (en) | 2024-08-08 |
| ES3017247T3 (en) | 2025-05-12 |
| IL296770B2 (en) | 2025-10-01 |
| EP4107252A1 (en) | 2022-12-28 |
| EP4107252B1 (en) | 2025-02-19 |
| CA3174017A1 (en) | 2022-06-02 |
| AU2021388811A1 (en) | 2022-11-03 |
| AU2021388811B2 (en) | 2023-02-23 |
| JP7601339B2 (ja) | 2024-12-17 |
| EP4006141A1 (en) | 2022-06-01 |
| PT4107252T (pt) | 2025-03-14 |
| CA3174017C (en) | 2025-05-06 |
| WO2022112218A1 (en) | 2022-06-02 |
| CN116209748A (zh) | 2023-06-02 |
| JP2024144435A (ja) | 2024-10-11 |
| EP4596674A2 (en) | 2025-08-06 |
| KR20220164801A (ko) | 2022-12-13 |
| FI4107252T3 (fi) | 2025-03-26 |
| KR102700433B1 (ko) | 2024-08-30 |
| DK4107252T3 (da) | 2025-03-17 |
| IL296770A (en) | 2022-11-01 |
| ZA202210745B (en) | 2023-05-31 |
| IL296770B1 (en) | 2025-06-01 |
| JP2023518919A (ja) | 2023-05-08 |
| EP4596674A3 (en) | 2025-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022013385A (es) | Metodo para la produccion de aav. | |
| Lv et al. | Single-cell RNA sequencing reveals regulatory mechanism for trophoblast cell-fate divergence in human peri-implantation conceptuses | |
| Yao et al. | Age‐associated changes in regenerative capabilities of mesenchymal stem cell: impact on chronic wounds repair | |
| BR112013025086A2 (pt) | sistema e métodos de biorreator multifuncional para classificação e cultura de células | |
| Jing et al. | MicroRNA-9 promotes differentiation of mouse bone mesenchymal stem cells into neurons by Notch signaling | |
| BRPI0710949A2 (pt) | Método para indução de diferenciação de células tronco pluripotentes em cardiomiócitos | |
| AR039465A1 (es) | Sistema multi plasmid para la produccion de virus influenza | |
| Bayley et al. | The productivity limit of manufacturing blood cell therapy in scalable stirred bioreactors | |
| PA8813901A1 (es) | Paramixovirus oncolíticos atenuados que codifican citoquinas de aves | |
| JP6495468B2 (ja) | リプログラミング前駆体組成物およびその使用方法 | |
| RU2010154132A (ru) | Варианты семейства, состоящего из 44 ксилоглюканаз | |
| Podestà et al. | Preterm cord blood contains a higher proportion of immature hematopoietic progenitors compared to term samples | |
| MX2021014456A (es) | Generacion rapida y deterministica de microglia a partir de celulas madre pluripotentes humanas. | |
| ES2530694T3 (es) | Factor de permisividad celular para virus, y usos del mismo | |
| CL2008003821A1 (es) | Metodo para producir el virus de la estomatitis vesicular (vsv) atenuado en celulas, que comprende: a) proporcionar una celula que comprende un gen g vsv optimizado e inducible, b) inducir la celula a expresar dicho gen, c) infectar la celula con un vsv atenuado, d) hacer crecer dichas celulas, y e) recuperar el vsv atenuado | |
| BR112014006794A2 (pt) | vetores com base em vírus da tristeza dos citros para expressão de gene/s estranho/s | |
| MX2022000002A (es) | Método para cultivo de células adherentes en un biorreactor multiparalelo. | |
| Ruiz-Gomez et al. | Steady-state persistence of respiratory syncytial virus in a macrophage-like cell line and sequence analysis of the persistent viral genome | |
| Li et al. | iPS cells generated without c-Myc have active Dlk1-Dio3 region and are capable of producing full-term mice through tetraploid complementation | |
| BRPI0914805B8 (pt) | método para replicar vírus em uma cultura de células scldk, processo para adaptar células cldk dependentes do substrato para desenvolvimento em suspensão, método para propagar continuamente células scldk em suspensão, e, composição | |
| CN106399370B (zh) | 一种建立稳定转基因的牙鲆胚胎细胞株方法 | |
| CN103255100B (zh) | 线粒体数目减少的人支气管上皮细胞株的建立和鉴定技术 | |
| CN113789296B (zh) | 高效诱导人脐带间充质干细胞分化为肝细胞的方法及应用 | |
| Zheng et al. | MicroRNAs in aging male reproduction | |
| Pozzo et al. | Comprehensive overview of non-coding RNAs in cardiac development |